BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 26056734)

  • 1. The association of serum-free light-chain levels with markers of renal function.
    Erdem BK; Davran F; Yilmaz VT; Çetinkaya R; Akbas H
    Ren Fail; 2015 Jul; 37(6):1057-60. PubMed ID: 26056734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular filtration rate as a determinant of free light chains in renal transplantation.
    Bargnoux AS; Simon N; Garrigue V; Dupuy AM; Badiou S; Mourad G; Cristol JP
    Clin Biochem; 2013 Nov; 46(16-17):1764-6. PubMed ID: 24028899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N Latex FLC serum free light-chain assays in patients with renal impairment.
    Jacobs JF; Hoedemakers RM; Teunissen E; Te Velthuis H
    Clin Chem Lab Med; 2014 Jun; 52(6):853-9. PubMed ID: 24406282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease.
    Molina-Andújar A; Robles P; Cibeira MT; Montagud-Marrahi E; Guillen E; Xipell M; Blasco M; Poch E; Rosiñol L; Bladé J; Quintana LF
    BMC Nephrol; 2020 Mar; 21(1):111. PubMed ID: 32234026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
    Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
    J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays.
    Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O
    Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.
    Hutchison CA; Harding S; Hewins P; Mead GP; Townsend J; Bradwell AR; Cockwell P
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1684-90. PubMed ID: 18945993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust Reference Intervals for Serum Kappa and Lambda Free Light Chains from a Multi Centre Study Population from Hyderabad, India: Myeloma Diagnostic Implications.
    Mohammed N; Chandran PA; Kandregula M; Mattaparthi RD; Gundeti S; Volturi J; Darapuneni R; Raju SB; Dattatreya PS
    Asian Pac J Cancer Prev; 2016; 17(5):2605-10. PubMed ID: 27268638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome.
    Wang C; Su W; Zhang W; Di Q; Duan MH; Ji W; Cao XX; Zhou DB; Li J
    Ann Hematol; 2014 Jul; 93(7):1201-6. PubMed ID: 24482101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of serum free light chain of patients with multiple myeloma and clinical significance thereof].
    Sui WW; Yao HJ; Wang YF; Wang L; Zhang K; Xu Y; Qiu LG
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(44):3158-60. PubMed ID: 18269880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Long-Term Storage on Serum Free Light Chain Stability.
    Hörber S; Klein R; Peter A
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum free light chain analysis: persisting limitations with new kids on the block.
    Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D
    Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical Significance of Serum Free Light Chain in Monoclonal Gammopathy].
    Lu H; Zhang W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):155-158. PubMed ID: 38387914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
    Böer K; Deufel T
    Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of serum free light chain levels in healthy adults immediately after marathon running.
    Campbell JP; Eijsvogels TM; Wang Y; Hopman MT; Jacobs JF
    Clin Chem Lab Med; 2016 Mar; 54(3):459-65. PubMed ID: 26351935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
    Zhao D; Jiang JQ; Lin L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal.
    Lamy T; Henri P; Lobbedez T; Comby E; Ryckelynck JP; Ficheux M
    Blood Purif; 2014; 37(2):93-8. PubMed ID: 24603634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The prognostic value of baseline serum free light chain in cardiac amyloidosis].
    Zhao L; Tian Z; Fang Q
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):186-90. PubMed ID: 26926369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.